Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Hypertension. 2020 Oct 12;76(6):1688–1695. doi: 10.1161/HYPERTENSIONAHA.120.14653

Table 1.

Selected characteristics and findings in three trials that evaluated intensive blood pressure lowering in stroke survivors.

Intensive Therapy Standard Therapy
Trial Sample
size
Mean
Age,
y
Follow-up,
y
Primary
outcome
Target
BP
Achieved
BP
Stroke
events
Target
BP
Achieved
BP
Stroke
events
SPS3 [17] 3020 63 3.7 Stroke <130 12/7 125 130-149 138 152
RESPECT [18] 1263 67 3.9 Stroke <120/80 127/77 39 <140/90 133/78 52
PAST-BP [19] 83 72 1.0 BP <130* 127/72 0 <140 129/74 3
PODCAST [20] 83 74 2.0 Cognitive function <125 130/73† 1 <140 140/77† 3
Total strokes 165 Total strokes 210

SPS3=Secondary Prevention of Small Cortical Strokes; RESPECT=Recurrent Stroke Prevention Clinical Outcome; PAST-BP=Prevention After Stroke-Blood Pressure.

*

or SBP reduction >10 mm Hg if starting SBP was <140 mm Hg.

**

at the six-month visit